Pyxis Oncology, Inc.
Company Stats
- Market Cap
- $194.3M
- as of Sep 30, 2026
- Shares Outstanding
- 83.4M
- Free Float
- 76.2%
Income Statement
- Revenue
- $13.9M
- Operating Income
- -$84.4M
- Net Income
- -$79.6M
- EBITDA
- -$79.9M
Cash Flow
- Free Cash Flow
- -$63.5M
- FCF Yield
- -32.7%
- Owner FCF Yield
- -38.8%
Balance Sheet
- Cash & Equivalents
- $15.4M
Returns & Capital
- SBC, 3Y Avg
- $13.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $13.9M | -$63.5M | -458.3% |
| FY2024 | $16.1M | -$57.9M | -358.7% |
| FY2023 | — | -$77.4M | — |
| FY2022 | — | -$95.7M | — |
| FY2021 | — | -$35.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges